PT Murni Sadar Tbk

JK:MTMH Indonesia Medical Care Facilities
Market Cap
$123.97 Million
Rp2.02 Trillion IDR
Market Cap Rank
#23934 Global
#304 in Indonesia
Share Price
Rp975.00
Change (1 day)
-2.99%
52-Week Range
Rp840.00 - Rp1405.00
All Time High
Rp2730.00
About

PT Murni Sadar Tbk, together with its subsidiaries, provides health services and manages private hospitals in Indonesia. The company offers outpatient installation services, including specialist, family health, general, dental, tropical diseases, travel medicine, and pain clinics; laboratory services, such as clinical pathology, blood bank, biomolecular/PCR, microbiology, and anatomical pathology… Read more

PT Murni Sadar Tbk (MTMH) - Net Assets

Latest net assets as of September 2025: Rp1.54 Trillion IDR

Based on the latest financial reports, PT Murni Sadar Tbk (MTMH) has net assets worth Rp1.54 Trillion IDR as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp2.64 Trillion) and total liabilities (Rp1.10 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Rp1.54 Trillion
% of Total Assets 58.26%
Annual Growth Rate 57.72%
5-Year Change 2712.7%
10-Year Change N/A
Growth Volatility 520.09

PT Murni Sadar Tbk - Net Assets Trend (2018–2024)

This chart illustrates how PT Murni Sadar Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for PT Murni Sadar Tbk (2018–2024)

The table below shows the annual net assets of PT Murni Sadar Tbk from 2018 to 2024.

Year Net Assets Change
2024-12-31 Rp1.42 Trillion +23.66%
2023-12-31 Rp1.15 Trillion -0.19%
2022-12-31 Rp1.15 Trillion +51.97%
2021-12-31 Rp757.03 Billion +1399.46%
2020-12-31 Rp50.49 Billion +0.98%
2019-12-31 Rp50.00 Billion -45.76%
2018-12-31 Rp92.18 Billion --

Equity Component Analysis

This analysis shows how different components contribute to PT Murni Sadar Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 491.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings Rp104.78 Billion 7.58%
Common Stock Rp206.85 Billion 14.97%
Other Comprehensive Income Rp737.35 Billion 53.38%
Other Components Rp332.42 Billion 24.06%
Total Equity Rp1.38 Trillion 100.00%

PT Murni Sadar Tbk Competitors by Market Cap

The table below lists competitors of PT Murni Sadar Tbk ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in PT Murni Sadar Tbk's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,124,012,231,978 to 1,381,401,366,000, a change of 257,389,134,022 (22.9%).
  • Net income of 5,180,195,000 contributed positively to equity growth.
  • Share repurchases of 7,550,000,000 reduced equity.
  • Other comprehensive income increased equity by 251,300,596,398.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Rp5.18 Billion +0.37%
Share Repurchases Rp7.55 Billion -0.55%
Other Comprehensive Income Rp251.30 Billion +18.19%
Other Changes Rp8.46 Billion +0.61%
Total Change Rp- 22.90%

Book Value vs Market Value Analysis

This analysis compares PT Murni Sadar Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.46x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 24.58x to 1.46x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 Rp39.67 Rp975.00 x
2019-12-31 Rp14.05 Rp975.00 x
2020-12-31 Rp20.46 Rp975.00 x
2021-12-31 Rp358.28 Rp975.00 x
2022-12-31 Rp548.06 Rp975.00 x
2023-12-31 Rp543.39 Rp975.00 x
2024-12-31 Rp667.82 Rp975.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently PT Murni Sadar Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.37%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.49%
  • • Asset Turnover: 0.45x
  • • Equity Multiplier: 1.72x
  • Recent ROE (0.37%) is above the historical average (-39.47%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 -10.29% -2.48% 0.44x 9.45x Rp-16.65 Billion
2019 -294.55% -19.30% 0.51x 30.17x Rp-88.51 Billion
2020 5.90% 0.44% 0.71x 19.03x Rp-1.73 Billion
2021 17.59% 13.26% 0.74x 1.80x Rp56.25 Billion
2022 5.82% 8.02% 0.50x 1.46x Rp-47.41 Billion
2023 -1.14% -1.39% 0.50x 1.65x Rp-125.23 Billion
2024 0.37% 0.49% 0.45x 1.72x Rp-132.96 Billion

Industry Comparison

This section compares PT Murni Sadar Tbk's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $4,135,853,885,916
  • Average return on equity (ROE) among peers: 27.59%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
PT Murni Sadar Tbk (MTMH) Rp1.54 Trillion -10.29% 0.72x $27.98 Million
Bundamedik Tbk PT (BMHS) $665.59 Billion 4.71% 1.10x $23.76 Million
Metro Healthcare Indonesia (CARE) $3.30 Trillion 0.18% 0.28x $411.41 Million
Medikaloka Hermina PT (HEAL) $2.37 Trillion 5.25% 0.76x $810.80 Million
Lippo Karawaci Tbk (LPKR) $23.57 Trillion -40.88% 1.20x $179.43 Million
Mitra Keluarga Karyasehat Tbk PT (MIKA) $3.28 Trillion 17.29% 0.13x $602.27 Million
Famon Awal Bros Sedaya (PRAY) $3.13 Trillion 6.43% 0.62x $52.90 Million
Royal Prima PT (PRIM) $722.89 Million 252.77% 36.50x $3.23 Million
PT Charlie Hospital Semarang Tbk (RSCH) $150.46 Billion -0.74% 0.03x $11.66 Million
Kedoya Adyaraya Tbk PT (RSGK) $751.16 Billion 3.35% 0.10x $3.08 Million